Germ-line DICER1 mutations do not make a major contribution to the etiology of familial testicular germ cell tumours

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Sabbaghian, Nelly ^a   Bahubeshi, Amin ^a,e   Shuen, Andrew Y ^a   Kanetsky, Peter A ^b,c   Tischkowitz, Marc D ^a,f   Nathanson, Katherine L ^c   Foulkes, William D ^a,d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dicer; Germ cell tumors; High resolution melt analysis; microRNA; Mutation analysis

Indexed keywords

DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; MICRORNA; RIBONUCLEASE III;

ARTICLE; DNA SEQUENCE; EXON; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; NEOPLASM; PROTEIN TERTIARY STRUCTURE; SEMINOMA; SINGLE NUCLEOTIDE POLYMORPHISM; TESTIS TUMOR; GERMLINE MUTATION;

DEAD-BOX RNA HELICASES; EXONS; GERM-LINE MUTATION; HUMANS; MALE; MICRORNAS; NEOPLASMS, GERM CELL AND EMBRYONAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEASE III; SEMINOMA; SEQUENCE ANALYSIS, DNA; TESTICULAR NEOPLASMS;

EID: 84875530058     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-127     Document Type: Article

References (23)

1. DICER1 mutations in familial pleuropulmonary blastoma. Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Science 2009 325 965 10.1126/science.1174334 19556464
2. Germline DICER1 mutations and familial cystic nephroma. Bahubeshi A, Bal N, Rio Frio T, Hamel N, Pouchet C, Yilmaz A, J Med Genet 2010 47 863 866 10.1136/jmg.2010.081216 21036787
3. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. Rio Frio T, Bahubeshi A, Kanellopoulou C, Hamel N, Niedziela M, Sabbaghian N, JAMA 2011 305 68 77 10.1001/jama.2010.1910 21205968
4. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. Slade I, Bacchelli C, Davies H, Murray A, Abbaszadeh F, Hanks S, J Med Genet 2011 48 273 278 10.1136/jmg.2010.083790 21266384
5. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Schultz KAP, Pacheco MC, Yang J, Williams GM, Messinger Y, Hill DA, Gynecol Oncol 2011 122 246 250 10.1016/j.ygyno.2011.03.024 21501861
6. Extending the phenotypes associated with DICER1 mutations. Foulkes WD, Bahubeshi A, Hamel N, Pasini B, Asioli S, Baynam G, Hum Mutat 2011 32 1381 1384 10.1002/humu.21600 21882293
7. New phenotype in the familial DICER1 tumor syndrome: Pituitary blastoma presenting at age 9 months. Wilid-Runge S, Bahubeshi A, Carret A, Crevier L, Robitaille Y, Kovacs K, Endocr Rev 2011 32 1 P777 10.1210/er.2011-0002
8. DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome. Doros L, Yang J, Dehner L, Rossi CT, Skiver K, Jarzembowski JA, Pediatr Blood Cancer 2012 59 558 560 10.1002/pbc.24020 22180160
9. Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma. Sabbaghian N, Hamel N, Srivastava A, Albrecht S, Priest JR, Foulkes WD, J Med Genet 2012 49 417 419 10.1136/jmedgenet-2012-100898 22717647
10. Recurrent Somatic DICER1Mutations in Nonepithelial Ovarian Cancers. Heravi-Moussavi A, Anglesio MS, Cheng S-WG, Senz J, Yang W, Prentice L, N Engl J Med 2012 366 234 242 10.1056/NEJMoa1102903 22187960
11. A method and server for predicting damaging missense mutations. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Nat Methods 2010 7 248 249 10.1038/nmeth0410-248 20354512
12. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Kumar P, Henikoff S, Ng PC, Nat Protoc 2009 4 1073 1081 10.1038/nprot.2009.86 19561590
13. In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. Gurtan AM, Lu V, Bhutkar A, Sharp PA, RNA 2012 18 1116 1122 10.1261/rna.032680.112 22546613
14. DICER1 RNase IIIb domain mutations are infrequent in testicular germ cell tumours. de Boer CM, Eini R, Gillis AM, Stoop H, Looijenga LH, White SJ, BMC Res Notes 2012 5 569 10.1186/1756-0500-5-569 23068969
15. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Kanetsky PA, Mitra N, Vardhanabhuti S, Li M, Vaughn DJ, Letrero R, Nat Genet 2009 41 811 815 10.1038/ng.393 19483682
16. A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Kanetsky PA, Mitra N, Vardhanabhuti S, Vaughn DJ, Li M, Ciosek SL, Hum Mol Genet 2011 20 3109 3117 10.1093/hmg/ddr207 21551455
17. Environmental and host factors in testicular germ cell tumors. McGlynn KA, Cancer Invest 2001 19 842 853 10.1081/CNV-100107746 11768038
18. Etiologic factors in testicular germ-cell tumors. McGlynn KA, Cook MB, Future Oncol 2009 5 1389 1402 10.2217/fon.09.116 19903067
19. Predisposition alleles for Testicular Germ Cell Tumour. Rapley EA, Nathanson KL, Curr Opin Genet Dev 2010 20 225 230 10.1016/j.gde.2010.02.006 20303738
20. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Hum Mol Genet 2006 15 443 451 16407372
21. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Am J Hum Genet 2005 77 1034 1043 10.1086/498455 16380914
22. Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour. Turnbull C, Rahman N, Int J Androl 2011 34 86 e96 10.1111/j.1365-2605.2011.01162.x 21623831
23. Rare de novo germline copy-number variation in testicular cancer. Stadler ZK, Esposito D, Shah S, Vijai J, Yamrom B, Levy D, Am J Hum Genet 2012 91 379 383 10.1016/j.ajhg.2012.06.019 22863192